Domiciliary noninvasive ventilation (DNIV) use in stable hypercapnic COPD is becoming increasingly widespread.However, factors related to compliance remain to be defined. Aim: Assess the predictive factors related to compliance to… Click to show full abstract
Domiciliary noninvasive ventilation (DNIV) use in stable hypercapnic COPD is becoming increasingly widespread.However, factors related to compliance remain to be defined. Aim: Assess the predictive factors related to compliance to domiciliary NIV in COPD patients and evaluate its impact on symptoms and hospitalization rate. Retrospective comparative study (2011- 2019) including stable hypercapnic COPD patients under DNIV for at least 1 year. Patients were divided in 2 groups: Group 1 (G1) « high-compliance » patients who used NIV regularly, night or daytime and ≥5 hours/d, and group (G2) « low-compliance » patients who used NIV irregularly and One hundred and forty patients with a mean age of 68±10.3 years were enrolled, of whom 86% were males. They were using DNIV for 2.3±2 years. the most common comorbidities were cardiac failure (67%) diabetes mellitus (65%),and obesity (52%). About 89.4% were using domiciliary long-term oxygen therapy .Of the patients, 87.4% were using the device in spontaneous time (ST) mode,12.6% in spontaneous (S) mode . Mean inspiratory positive airway pressure (IPAP) used was 18±5.5 cmH2O, and mean expiratory positive airway pressure was 5.8±1.3 cmH2O. ST mode was more frequent in G1 (56 % vs 74% p Accurate determination of the patients who have better compliance to NIV will enable better patient selection and also help in defining optimal ventilator
               
Click one of the above tabs to view related content.